Application 021292
- Type
- NDA
- Sponsor
- PROVELL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 002 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 003 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 004 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 005 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 006 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 007 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 008 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 009 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 010 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 011 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | No | No |
| 012 | EUTHYROX | LEVOTHYROXINE SODIUM | TABLET;ORAL | 0.3MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021292-001 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.025MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-002 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.05MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-003 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.075MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-004 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.088MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-005 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.1MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-006 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.112MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-007 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.125MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-008 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.137MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-009 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.15MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-010 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.175MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-011 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.2MG | TABLET / ORAL | 2002-05-31 | ||
| N021292-012 | EUTHYROX | LEVOTHYROXINE SODIUM | 0.3MG | TABLET / ORAL | 2002-05-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-005 | EUTHYROX | 0.1MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-006 | EUTHYROX | 0.112MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-007 | EUTHYROX | 0.125MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-008 | EUTHYROX | 0.137MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-009 | EUTHYROX | 0.15MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-010 | EUTHYROX | 0.175MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-011 | EUTHYROX | 0.2MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N021292-012 | EUTHYROX | 0.3MG | TABLET / ORAL | 2002-05-31 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-001 | EUTHYROX | 0.025MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-002 | EUTHYROX | 0.05MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-003 | EUTHYROX | 0.075MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021292-004 | EUTHYROX | 0.088MG | TABLET / ORAL | 2002-05-31 | caaa826d4ba7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021292-001 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-002 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-003 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-004 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-005 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-006 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-007 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-008 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-009 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-010 | AB2 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021292-011 | AB2 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-001 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-002 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-003 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-004 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-005 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-006 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-007 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-008 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-009 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-010 | AB2 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021292-011 | AB2 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-001 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-002 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-003 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-004 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-005 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-006 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-007 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-008 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-009 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-010 | AB2 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021292-011 | AB2 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-001 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-002 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-003 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-004 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-005 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-006 | AB2 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021292-007 | AB2 | 1 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 52a07ade-4098-477d-874e-dd692667041e | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 67f46137-afc4-471b-a6c7-9c2aef92da5d | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 70a9bb5c-2259-405e-8d89-cc1db8c70743 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 6f4998ac-0714-4f5d-8944-9e6902b9f0a6 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 853d9e86-2b5b-4967-8c22-70ad34f03418 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b42fe9dd-8383-4839-9eab-393de388da71 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | fa7dd488-de7e-4f9e-87db-18391b723aad | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 394b1006-c160-4668-8684-82d1c4481202 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 8e11401b-f5c2-42ac-ba63-2e71b5626b7e | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 4520fae0-acce-47a0-af9e-f4f16ea6b268 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2ce47caf-6ece-429c-b5d7-c47ba6952800 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 99df68ea-4de7-4825-a6d7-894c70d01c28 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 4f26f9dc-cf49-4b55-a6f7-f2f579893ee4 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2b737395-0238-400b-95ff-890b95c98425 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | ASCLEMED USA INC. | 42a26f8a-dc67-42e4-abb0-d2602afb1b7d | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 1ac29774-2b53-4a3f-97fa-16c2880a0868 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b717aff6-f754-458d-be87-d12d87c5da00 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 62de26a8-d6fc-463f-abe6-4656228c3142 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ffc34bc6-5de5-addb-e053-6294a90a25be | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 49136b34-1bc1-ec4e-e063-6394a90ac9dd | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | LEVOTHYROXINE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-025 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-050 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-075 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-088 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-100 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-112 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-125 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-137 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-150 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-175 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
| 72305-200 | EUTHYROX | levothyroxine sodium | Provell Pharmaceuticals, LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 70915 | SUPPL | 2022-05-03 |
| 70873 | SUPPL | 2022-05-02 |
| 55504 | SUPPL | 2018-09-18 |
| 55503 | SUPPL | 2018-09-18 |
| 55502 | SUPPL | 2018-09-18 |
| 55498 | SUPPL | 2018-09-18 |
| 55497 | SUPPL | 2018-09-18 |
| 55496 | SUPPL | 2018-09-18 |
| 36600 | SUPPL | 2009-04-03 |
| 4947 | SUPPL | 2009-04-01 |
| 21579 | ORIG | 2004-06-29 |
| 15125 | ORIG | 2002-05-31 |
| 4946 | ORIG | 2002-05-31 |